Classification of medicinal products in Belgium

被引：0
|
作者：
Goulard, Philippe [1 ]
机构：
[1] Clin St Luc, B-5004 Bouge, Belgium
来源：
EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE | 2012年 / 19卷 / 04期
关键词：
D O I：
10.1136/ejhpharm-2012-000119
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：390 / 390
页数：1
相关论文
共 50 条
  • [1] PHARMACEUTICAL REIMBURSEMENT OF INNOVATIVE MEDICINAL PRODUCTS IN BELGIUM
    Van Wilder, P.
    Bormans, V
    VALUE IN HEALTH, 2016, 19 (07) : A467 - A467
  • [2] New procedure for registration of veterinary medicinal products in Belgium
    Pastoret, PP
    Falize, F
    Laurier, L
    ANNALES DE MEDECINE VETERINAIRE, 1998, 142 (02) : 93 - +
  • [3] Access to orphan medicinal products in Belgium: Quality of clinical evidence
    Dupont, A. G.
    Van Wilder, P. B.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (05) : 734 - 734
  • [4] The ATCvet classification system for veterinary medicinal products
    Dahlin, A
    Eriksson, A
    Kjartansdóttir, T
    Markestad, A
    Odensvik, K
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2001, 24 (02) : 141 - 142
  • [5] ATCVET - A CLASSIFICATION-SYSTEM FOR VETERINARY MEDICINAL PRODUCTS
    HAMRING, A
    JANZON, U
    KANNIKOSKI, A
    KRISTINSDOTTIR, G
    MARKESTAD, A
    MYHR, R
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1993, 16 (03) : 380 - 381
  • [6] Veterinary medicinal products authorisation and classification in the Republic of Ireland
    Murphy, D
    IRISH VETERINARY JOURNAL, 2000, 53 (06) : 320 - +
  • [7] The new European registration system for veterinary medicinal products. The impact in Belgium.
    Falize, F
    Pastoret, PP
    ANNALES DE MEDECINE VETERINAIRE, 1996, 140 (05) : 329 - &
  • [8] The classification of antiseptic products to be administered to wounds -: another borderline case between medicinal products and medical devices?
    Kramer, A.
    Kremer, J.
    Assadian, O.
    Schneider, I.
    Daehne, H.
    Schwemmer, J.
    Mueller, G.
    Siegmund, W.
    Jaekel, C.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2006, 44 (12) : 677 - 692
  • [9] Impact of health technology assessment and managed entry schemes on reimbursement decisions of centrally authorised medicinal products in Belgium
    Van Wilder, Philippe
    Pirson, Magali
    Dupont, Alain
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (07) : 895 - 900
  • [10] Impact of health technology assessment and managed entry schemes on reimbursement decisions of centrally authorised medicinal products in Belgium
    Philippe Van Wilder
    Magali Pirson
    Alain Dupont
    European Journal of Clinical Pharmacology, 2019, 75 : 895 - 900
12345